582 institutions reported holding $18.19B of BRIDGEBIO PHARMA INC (BBIO) in SEC 13F filings for 2026-06-30. Largest institutional holders: VANGUARD GROUP INC ($1.26B), Jupiter Topco LLC ($1.05B), Kohlberg Kravis Roberts & Co. L.P. ($988.3M), BlackRock, Inc. ($823.8M), FARALLON CAPITAL MANAGEMENT LLC ($800.1M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30